Uqora Maximum Uti Pain Relief
426317e7-a925-116a-e063-6294a90a52dc
34390-5
HUMAN OTC DRUG LABEL
Drug Facts
Composition & Product
Identifiers & Packaging
Description
Phenazopyridine Hydrochloride 99.5 mg .
Purpose
Urinary Tract Analgesic
Medication Information
Purpose
Urinary Tract Analgesic
Description
Phenazopyridine Hydrochloride 99.5 mg .
Use
Fast relief from urinary pain, burning, urgency and frequency associated with urinary tract infections. Treatment should not exceed 2 days; see Directions.
Section 50565-1
Keep out of reach of children. In case of an overdose, get medical help or contact a Poison Control Center right away 1-800-222-1222.
Section 50566-9
Stop use and ask doctor if
■ your symptoms last for more than 2 days
■ you suspect you are having an adverse reaction to the medication
Section 50567-7
When using this product
■ stomach upset may occur, taking this product with or after meals may reduce stomach upset
■ your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.
----
■ Long-term administration of phenazopyridine hydrochloride has induced neoplasia in rats (large intestine) andmice (liver). Although no association between phenazopyridine hydrochloride and human neoplasia has beenreported, adequate epidemiological studies along these lines have not been conducted.
Section 50569-3
Ask doctor before use if you have
■ kidney disease
■ allergies to foods, preservatives or dyes
■ had a hypersensitive reaction to phenazopyridine
Section 50570-1
Do not use: if you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician.
Section 51945-4
MAX STRENGTH MOST POWERFUL DOSE WITHOUT RX
uqora
FOUNDED BY A UTI SUFFERER
UTI PAIN RELIEF
MAX STRENGTH
FAST TARGETED RELIEF FOR
Burning
Pain & discomfort at the source unlike general pain relievers
Urgency
2 Day Supply
12 tablets
99.5 mg Phenazopyridine Hydrochloride
Not intended to replace medical care
Section 53414-9
If pregnant or breast feeding, ask a health professional before use.
Warnings
Do not exceed recommended dosage
Directions
Adults and children 12 years and over:
■ take 2 tablets 3 times daily with a full glass of water, with or after meals as needed
■ Do not use for more than 2 days (12 tablets) without consulting a doctor.
Children under 12 years:
■ consult a doctor
Other Information
■ this product may stain contact lenses ■ this product can interfere with laboratorytests including urine, glucose (sugar), and ketones tests ■ store at room temperature 15°-30°C (59°-86°F) in adry place and protect from light ■ Tamper evident: tablets sealed in blisters. Do not use if blister foil or seal isopen or damaged
Inactive Ingredients
corn starch, croscarmellose sodium, hypromellose, lactose, magnesium stearate,microcrystalline cellulose, polyethylene glycol, polyvinylpyrrolidone, pregelatinized starch, silicon dioxide, sodiumstarch glycolate, talc and triacetin
Active Ingredient (in Each Tablet)
Phenazopyridine Hydrochloride 99.5 mg .
Structured Label Content
Use
Fast relief from urinary pain, burning, urgency and frequency associated with urinary tract infections. Treatment should not exceed 2 days; see Directions.
Section 50565-1 (50565-1)
Keep out of reach of children. In case of an overdose, get medical help or contact a Poison Control Center right away 1-800-222-1222.
Section 50566-9 (50566-9)
Stop use and ask doctor if
■ your symptoms last for more than 2 days
■ you suspect you are having an adverse reaction to the medication
Section 50567-7 (50567-7)
When using this product
■ stomach upset may occur, taking this product with or after meals may reduce stomach upset
■ your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.
----
■ Long-term administration of phenazopyridine hydrochloride has induced neoplasia in rats (large intestine) andmice (liver). Although no association between phenazopyridine hydrochloride and human neoplasia has beenreported, adequate epidemiological studies along these lines have not been conducted.
Section 50569-3 (50569-3)
Ask doctor before use if you have
■ kidney disease
■ allergies to foods, preservatives or dyes
■ had a hypersensitive reaction to phenazopyridine
Section 50570-1 (50570-1)
Do not use: if you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician.
Section 51945-4 (51945-4)
MAX STRENGTH MOST POWERFUL DOSE WITHOUT RX
uqora
FOUNDED BY A UTI SUFFERER
UTI PAIN RELIEF
MAX STRENGTH
FAST TARGETED RELIEF FOR
Burning
Pain & discomfort at the source unlike general pain relievers
Urgency
2 Day Supply
12 tablets
99.5 mg Phenazopyridine Hydrochloride
Not intended to replace medical care
Section 53414-9 (53414-9)
If pregnant or breast feeding, ask a health professional before use.
Purpose
Urinary Tract Analgesic
Warnings
Do not exceed recommended dosage
Directions
Adults and children 12 years and over:
■ take 2 tablets 3 times daily with a full glass of water, with or after meals as needed
■ Do not use for more than 2 days (12 tablets) without consulting a doctor.
Children under 12 years:
■ consult a doctor
Other Information (Other information)
■ this product may stain contact lenses ■ this product can interfere with laboratorytests including urine, glucose (sugar), and ketones tests ■ store at room temperature 15°-30°C (59°-86°F) in adry place and protect from light ■ Tamper evident: tablets sealed in blisters. Do not use if blister foil or seal isopen or damaged
Inactive Ingredients (Inactive ingredients)
corn starch, croscarmellose sodium, hypromellose, lactose, magnesium stearate,microcrystalline cellulose, polyethylene glycol, polyvinylpyrrolidone, pregelatinized starch, silicon dioxide, sodiumstarch glycolate, talc and triacetin
Active Ingredient (in Each Tablet) (Active ingredient (in each tablet))
Phenazopyridine Hydrochloride 99.5 mg .
Advanced Ingredient Data
Raw Label Data
All Sections (JSON)
Additional Information
Back to search View SPL set listing Open on DailyMed ↗
Source: dailymed · Ingested: 2026-02-15T12:08:51.802458 · Updated: 2026-03-14T23:13:18.140905